EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting the cytokine-epigenetic axis: a new paradigm and prospects for disease treatment

Yuyue Luo, Yikan Zheng, Jie Qin, Jinwei Liu, Yuhan Ma, Jingda Li, Jun Li, Wenlong Sun, Qian Zhang, Mengyao Li

European Cytokine Network · 2026

DOI: 10.32604/ecn.2026.082885 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Cytokine Network, 2026. Verfasst von Yuyue Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences and Medicine, Shandong University of Technology, Zibo, China. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Cytokines. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Gefördert von: Natural Science Foundation of Hubei Province, Science and Technology Department of Xizang Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytokines, as key signaling molecules, are involved in the regulation of physiological and pathological processes such as inflammation, immunity, and cell growth. Epigenetic mechanisms, including DNA methylation, histone modifications, chromatin remodeling, and non-coding RNAs, enable precise control of gene expression without changing the DNA sequence. Recent studies have revealed that cytokines interact with epigenetic regulation to form a dynamic and complex "cytokine-epigenetic axis". Through metabolic reprogramming and regulation of epigenetic enzyme activity, this axis affects gene expression patterns at both transcriptional and post-transcriptional levels, thereby contributing to the initiation and progression of various diseases, including autoimmune diseases, neurodegenerative diseases, neuropsychiatric disorders, metabolic diseases, and cancer. Targeting this regulatory axis by combining interventions on upstream cytokine signaling and downstream epigenetic enzymes represents a new precision therapeutic strategy for overcoming resistance to monotherapy and achieving disease-modifying treatment. This review describes how cytokines regulate epigenetic modification substrates through metabolic reprogramming and directly regulate epigenetic enzyme activity via JAK-STAT, NF-κB, and TGF-β/Smad pathways; how this axis drives disease chronicity and therapy resistance across autoimmune, neurodegenerative, metabolic, and neoplastic diseases by establishing long-lasting functional reprogramming; and emerging strategies targeting this axis through combined interventions, precision medicine, and disease memory reprogramming.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticCytokinesHumansAnimalsSignal TransductionNeoplasmsDNA MethylationNeurodegenerative DiseasesMetabolic ReprogrammingMetabolic Diseases

Stichwörter der Autor:innen

CytokinesDNA methylationepigeneticshistone modificationsimmunometabolismtargeted therapy

Substanzen

Cytokines

Autor:innen und Institutionen

  • School of Life Sciences and Medicine, Shandong University of Technology, Zibo, China.
  • First Clinical Medical College, Inner Mongolia Medical University, Hohhot, China.
  • College of Life Science, Yangtze University, Jingzhou, China.
  • College of Pharmacy, Inner Mongolia Medical University, Hohhot, China.
  • State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shanghai Key Laboratory for Cancer Systems Regulation and Clinical Translation, Shanghai Jiading District Central Hospital, Shanghai, China.

Förderung

  • Natural Science Foundation of Hubei Province
  • Science and Technology Department of Xizang Autonomous Region

Zitieren

APA

Luo, Y., Zheng, Y., Qin, J., Liu, J., Ma, Y., Li, J., Li, J., Sun, W., Zhang, Q., & Li, M. (2026). Targeting the cytokine-epigenetic axis: a new paradigm and prospects for disease treatment. European Cytokine Network. https://doi.org/10.32604/ecn.2026.082885

Vancouver

Luo Y, Zheng Y, Qin J, Liu J, Ma Y, Li J, et al. Targeting the cytokine-epigenetic axis: a new paradigm and prospects for disease treatment. European Cytokine Network. 2026. doi:10.32604/ecn.2026.082885

BibTeX
@article{Luo2026,
  author = {Luo, Yuyue and Zheng, Yikan and Qin, Jie and Liu, Jinwei and Ma, Yuhan and Li, Jingda and Li, Jun and Sun, Wenlong and Zhang, Qian and Li, Mengyao},
  title = {Targeting the cytokine-epigenetic axis: a new paradigm and prospects for disease treatment},
  journal = {European Cytokine Network},
  year = {2026},
  doi = {10.32604/ecn.2026.082885}
}
Kostenlos starten →